Showing results (1-10 of 129) with videos related to
Sort By:
Pageof 13
Duodecim; Laaketieteellinen Aikakauskirja|February 20, 2014
[Does carcinoma originating in the ovary exist?]Ralf BützowDuodecim; Laaketieteellinen Aikakauskirja|July 8, 2016
[Malignized dermoid cyst of the ovary]Riitta Koivisto-Korander, Ralf BützowModern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 16, 2020
Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in endometrioid endometrial carcinomaAnnukka Pasanen, Mikko Loukovaara, Ralf BützowDuodecim; Laaketieteellinen Aikakauskirja|December 8, 2015
[Is endometriosis a premalignant condition to ovarian carcinoma?]Heini Lassus, Annukka Pasanen, Ralf BützowCancers|July 2, 2021
Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Molecularly Classified Endometrial CarcinomaMikko Loukovaara, Annukka Pasanen, Ralf BützowJournal of Clinical Pathology|May 31, 2022
Molecular classification of endometrial carcinoma: a clinically oriented reviewMikko Loukovaara, Annukka Pasanen, Ralf BützowInternational Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 31, 2026
Evaluation of the new European risk classification for endometrial carcinoma: a cohort studyMikko Loukovaara, Annukka Pasanen, Ralf BützowCancers|February 15, 2022
Clinicopathologic vs. Molecular Integrated Prognostication of Endometrial Carcinoma by European GuidelinesMikko Loukovaara, Annukka Pasanen, Ralf BützowInternational Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|June 26, 2024
Stage distribution and prognostic accuracy of the 2023 FIGO (the International Federation of Gynecology & Obstetrics) staging system for endometrial cancer: A retrospective cohort studyMikko Loukovaara, Annukka Pasanen, Ralf BützowInternational Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|July 2, 2026
Tumor Grade in Molecularly Defined Endometrial Carcinoma: Prognostic Implications of the ESGO-ESTRO-ESP 2025 GuidelinesMikko Loukovaara, Annukka Pasanen, Ralf BützowPageof 13